Clinical Trials Logo

Clinical Trial Summary

This study is designed as a prospective comparative randomized clinical study to determine the diagnostic accuracy (sensitivity, specificity, positive predictive value, and negative predictive value) of pulsed fluoroscopy retrograde urethrogram for urethral stricture disease. The target population includes patients scheduled for retrograde urethrogram either new referral or follow up at Thunder Bay Regional Health Sciences Centre (TBRHSC) for treatment of urethral stricture who meet the specific eligibility criteria. The overall number of participants targeted will be 46. Upon presentation to the urology clinic or ambulatory care unit, the treating urologist/investigator will notify the patient of an opportunity to participate in the study. If the patient is interested, a research team member who is not directly involved in the patient care will be invited to discuss the study to the potential participant. The study team member will obtain a full-informed consent form the potential participant. Following informed consent, participants will be screened to ensure they meet the specific eligibility requirements of this study, through consultation with their medical records and the treating urologist. Randomization will be conducted in a 1:1 allocation ratio to either treatment arm: (1) the Pulsed fluoroscopy retrograde urethrogram, or (2) the Traditional retrograde urethrogram. Using an Excel sheet, the RAND function will give a random code. The random code is a figure ranging from 0.00000000 to 0.9999999999. A 0.5 cut-off code will be used, below which we will use the small blocks of 4 cells (4 rows of excel) and above which we will use the large blocks of 8 cells (8 rows of excel). Participants will undergo procedures according to the order of randomization Participants will undergo either Pulsed fluoroscopy retrograde urethrogram or Traditional retrograde urethrogram, depending on the treatment arm they are randomized to. Clinical data such as stricture location, stricture length and possible adverse effects will be recorded. According to the urologist decision based on data obtained during RUG, participant will be scheduled for urethroplasty or cystoscopy. All participants will undergo these procedures according to standard care procedures at TBRHSC. Data collection at baseline will include demographics, and relevant medical history. All retrograde urethrogram data including the type of urethrogram, the urethrogram date, fluoroscopy time, cumulative radiation dose, stricture location, stricture length and intraprocedural complications. Furthermore, we will record intraoperative data such as operative date, stricture location and stricture length. De-identified research files will be maintained in a secure office of a research team member during the conduct of the study. De-identified research data will be input into an electronic database that is password protected and maintained on research team member's computers or encrypted USB devices. An enrolment log, linking Participant ID to identifiable information will be maintained in hard copy in a locked office, or electronically as a password-protected document on the TBRHSC network. Only delegated research team members and the Principal Investigator will have access to research and patient data. Upon study closure, research records will be kept in secure storage in a research team member's office for a period of 5 years. Following this, the files will be securely shredded, and any electronic documents permanently deleted. Data will be analyzed using the commercially available SPSS software version 26 (SPSS Inc., Chicago, IL, USA). For both techniques, data obtained during baseline and postoperative urethrograms will be compared in terms of stricture location, stricture length, fluoroscopy time, cumulative radiation dose and the occurrence of intraprocedural complications. Categorical data will be compared using Chi-squared or Fisher test. Continuous data will be analyzed using the T test or Mann-Whitney U test Data obtained during urethroplasty will set as a standard of comparison to determine sensitivity, specificity, positive predictive value and negative predictive value of pulsed fluoroscopy and traditional urethrograms. For each comparison, 2 × 2 contingency tables were used to present the results and calculate the diagnostic accuracy estimates with 95% confidence intervals Data analysis will be done blindly regarding the type of performed procedure. One procedure will be coded as "1" and the other will "2". Categorical variables will be presented using number and percentage, and continuous variables will be presented using median and ranges. Two-tailed p-values of less than 0.05 will be set for statistical significance.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05519566
Study type Interventional
Source Northern Ontario School of Medicine
Contact Walid Shahrour, MD
Phone (807) 285-9292
Email Walid.Shahrour@tbh.net
Status Recruiting
Phase N/A
Start date September 1, 2022
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT03572348 - VeSpAR: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures. N/A
Completed NCT02321670 - Scandinavian Urethroplasty Study N/A
Recruiting NCT04071925 - 9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
Terminated NCT02551783 - Dorsal vs. Ventral Buccal Graft Dorsal vs. Ventral Buccal Graft N/A
Active, not recruiting NCT03270384 - Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease N/A
Completed NCT03973619 - Urethral Stricture: A Comparison Between Jugal or Labial Graft Urethroplasty N/A
Recruiting NCT04965025 - Multi-stage Urethroplasty With Augmentation Using a Dorsal Graft Inlay Technique Comparing Graft Use in First or Second Stage N/A
Withdrawn NCT03851952 - Re-Establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease - Registry Study N/A
Recruiting NCT04161365 - Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Urethral Strictures N/A
Completed NCT02948842 - Clostridium Histolyticum Collagenase Injection for Urethral Disease Phase 2
Not yet recruiting NCT03258658 - Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures Phase 1
Not yet recruiting NCT06384066 - Mobile Health Application to Improve Patient Satisfaction After Urethroplasty N/A
Completed NCT03859024 - Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty Phase 4
Not yet recruiting NCT06064968 - Effectiveness of Intermittent Bladder Catheterization (IBC) in Reducing Recurrence of Urethral Stricture N/A
Active, not recruiting NCT03499964 - ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease N/A
Terminated NCT02634619 - A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty N/A
Not yet recruiting NCT00918528 - Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy Phase 1/Phase 2
Completed NCT05078788 - Holmium Laser Uretherotomy in Combination With Intralesional Steroids in Bulbar Uretheral Stricture N/A
Enrolling by invitation NCT03205670 - Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers Early Phase 1
Recruiting NCT05464290 - The Nanofat Regenerative Surgery for Management of Genital Lichen Sclerosus in Male and Female Patients N/A